O. I. Trushina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
O. I. Trushina has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra S. Shilova
S.S. Yudin Moscow City Clinical Hospital, Moscow Healthcare Department
2 shared publications - Andrei Dmitrievich Kaprin
RUDN University
2 shared publications - Dmitriy Yu. Shchekochikhin
I.M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - Oleg I. Apolikhin
N.A. Lopatkin Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Center, Ministry of Health of Russia
2 shared publications - Platon D. Lopukhov
I.M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - Sergeevna Yudina Victoria
Department of Public Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia
2 shared publications
Latest Publications
- Open Access
- 13 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (6) , 1934
Prognostic Markers of Adverse Outcomes in Acute Heart Failure: Use of Machine Learning and Network Analysis with Real Clinical Data
Background: Acute heart failure (AHF) is one of the leading causes of admissions to the emergency department (ED). There is a need to develop an easy-to-use score that can be used in the ED to risk-stratify patients with AHF and in hospitalization decisions regarding cardiac wards or intensive care units (ICUs). Methods: A retrospective observational study was conducted at a city hospital. The data from the presentation of AHF patients at the ED were collected. The combined primary endpoint included death from any cause during hospitalization or transfer to an intensive care unit (ICU) for using inotropes/vasopressors. Feature selection was performed using artificial intelligence. Results: From August 2020 to August 2021, 908 patients were enrolled (mean age: 71.6 ± 13 years; 500 (55.1%) men). We found significant predictors of in-hospital mortality and ICU transfers for inotrope/vasopressor use and built two models to assess the need for ICU admission of patients from the ED. The first model included SpO2 < 90%, QTc duration, prior diabetes mellitus and HF diagnosis, serum chloride concentration, respiratory rate and atrial fibrillation on admission, blood urea nitrogen (BUN) levels, and any implanted devices. The second model included left ventricular end-diastolic size, systolic blood pressure, pulse blood pressure, BUN levels, right atrium size, serum chloride, sodium and uric acid concentrations, prior loop diuretic use, and pulmonary artery systolic blood pressure. Conclusions: We developed two models that demonstrated a high negative predictive value, which allowed us to distinguish patients with low risk and determine patients who can be hospitalized and sent from the ED to the floor. These easy-to-use models can be used at the ED.
- 13 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (6) , 1934
Open AccessPrognostic Markers of Adverse Outcomes in Acute Heart Failure: Use of Machine Learning and Network Analysis with Real Clinical Data
Background: Acute heart failure (AHF) is one of the leading causes of admissions to the emergency department (ED). There is a need to develop an easy-to-use score that can be used in the ED to risk-stratify patients with AHF and in hospitalization decisions regarding cardiac wards or intensive care units (ICUs). Methods: A retrospective observational study was conducted at a city hospital. The data from the presentation of AHF patients at the ED were collected. The combined primary endpoint included death from any cause during hospitalization or transfer to an intensive care unit (ICU) for using inotropes/vasopressors. Feature selection was performed using artificial intelligence. Results: From August 2020 to August 2021, 908 patients were enrolled (mean age: 71.6 ± 13 years; 500 (55.1%) men). We found significant predictors of in-hospital mortality and ICU transfers for inotrope/vasopressor use and built two models to assess the need for ICU admission of patients from the ED. The first model included SpO2 < 90%, QTc duration, prior diabetes mellitus and HF diagnosis, serum chloride concentration, respiratory rate and atrial fibrillation on admission, blood urea nitrogen (BUN) levels, and any implanted devices. The second model included left ventricular end-diastolic size, systolic blood pressure, pulse blood pressure, BUN levels, right atrium size, serum chloride, sodium and uric acid concentrations, prior loop diuretic use, and pulmonary artery systolic blood pressure. Conclusions: We developed two models that demonstrated a high negative predictive value, which allowed us to distinguish patients with low risk and determine patients who can be hospitalized and sent from the ED to the floor. These easy-to-use models can be used at the ED.
- Open Access
- 15 January 2024
- Published by Publishing House ABV Press in The Clinician
- Vol. 18 (1) , 70-77
Autoimmune/inflammatory syndrome induced by adjuvants in a patient after implantation of a polypropylene mesh for inguinal hernia repair (clinical case)
Aim. To report a clinical case of autoimmune/inflammatory syndrome, induced by adjuvants in patient after polypropylene mesh implantation for inguinal hernia repair.Materials and methods. Patient Z., male, 68 years old, was admitted to the hospital presenting muscle weakness and progressive dyspnoea. Interview and physical exam revealed signs of cognitive impairment and memory loss, proximal muscle weakness. Differential diagnosis was made to clarify genesis of symptoms, to rule out polymyositis, other systemic connective tissue diseases, oncologic diseases, hypothyroidism, infectious diseases.Results. Creatine kinase, thyroxine, thyreothropic hormone levels were normal. Clinical and immunological investigation revealed no data on polymyositis or any other systemic connective tissue disease. Yersiniosis, salmonellosis, malaria were ruled out. Chest CT scan, abdomen CT scan, gastroscopy, colonoscopy no data on the presence of malignant neoplasms. PSA level were normal. Electroneuromyography revealed signs of symmetrical axonal type damage to the motor portion of the ulnar nerves on both sides, and demyelinating type damage to the sensory portion. Prednisolone therapy was started at a dose of 40 mg per 24 hour (0.5 mg per kg), which lead to a significant clinical improvement. Based on the therapy response and positive diagnostic criteria (clinical manifestation after polypropylene mesh implantation, typical clinical manifestation – muscle weakness, chronic fatigue, cognitive impairment, neurological manifestations associated with demyelination) patient was diagnosed with autoimmune/inflammatory syndrome, induced by adjuvants (ASIA) after polypropylene mesh implantation for inguinal hernia repair.Conclusion. This clinical case report demonstrates possibility of a persistent course of the disease (symptoms were present for 15 years). Feature of this case is partial clinical improvement due to long-term uncontrolled dexamethasone use, which was prescribed empirically.
- 15 January 2024
- Published by Publishing House ABV Press in The Clinician
- Vol. 18 (1) , 70-77
Open AccessAutoimmune/inflammatory syndrome induced by adjuvants in a patient after implantation of a polypropylene mesh for inguinal hernia repair (clinical case)
Aim. To report a clinical case of autoimmune/inflammatory syndrome, induced by adjuvants in patient after polypropylene mesh implantation for inguinal hernia repair.Materials and methods. Patient Z., male, 68 years old, was admitted to the hospital presenting muscle weakness and progressive dyspnoea. Interview and physical exam revealed signs of cognitive impairment and memory loss, proximal muscle weakness. Differential diagnosis was made to clarify genesis of symptoms, to rule out polymyositis, other systemic connective tissue diseases, oncologic diseases, hypothyroidism, infectious diseases.Results. Creatine kinase, thyroxine, thyreothropic hormone levels were normal. Clinical and immunological investigation revealed no data on polymyositis or any other systemic connective tissue disease. Yersiniosis, salmonellosis, malaria were ruled out. Chest CT scan, abdomen CT scan, gastroscopy, colonoscopy no data on the presence of malignant neoplasms. PSA level were normal. Electroneuromyography revealed signs of symmetrical axonal type damage to the motor portion of the ulnar nerves on both sides, and demyelinating type damage to the sensory portion. Prednisolone therapy was started at a dose of 40 mg per 24 hour (0.5 mg per kg), which lead to a significant clinical improvement. Based on the therapy response and positive diagnostic criteria (clinical manifestation after polypropylene mesh implantation, typical clinical manifestation – muscle weakness, chronic fatigue, cognitive impairment, neurological manifestations associated with demyelination) patient was diagnosed with autoimmune/inflammatory syndrome, induced by adjuvants (ASIA) after polypropylene mesh implantation for inguinal hernia repair.Conclusion. This clinical case report demonstrates possibility of a persistent course of the disease (symptoms were present for 15 years). Feature of this case is partial clinical improvement due to long-term uncontrolled dexamethasone use, which was prescribed empirically.
- Open Access
- 23 June 2023
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 43 (3) , 113-120
Manifestations of the incidence of malignant neoplasms of the reproductive system in the young population of Russian Federation: regional features
The aim of the study was to analyze the incidence of malignant neoplasms of the organs of the reproductive system of the population aged 15 to 39 years within the Russian Federation.Material and methods. The data of specialized forms of state reporting No. 7 “Information on diseases of malignant neoplasms” and data of the Federal State Statistics Service of the Russian Federation on the size and sex and age composition of the population for the period from 2011 to 2021 were used.Results. In the dynamics of changes in the incidence of malignant neoplasms of the reproductive organs of the young population of the regions of the Russian Federation for the period from 2011 to 2021, multidirectional trends are observed. The highest incidence rates are in the Siberian and Far Eastern Federal Districts, namely in the Trans-Baikal Territory and the Magadan Region, the smallest – in the regions of the North Caucasian Federal District.Conclusions. Regional differences in incidence rates in the constituent entities of the Russian Federation were established, changes in trends were found for the age group of people from 15 to 39 years old, which may be associated with lifestyle changes, environmental factors, as well as improved detection of cancer.
- 23 June 2023
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 43 (3) , 113-120
Open AccessManifestations of the incidence of malignant neoplasms of the reproductive system in the young population of Russian Federation: regional features
The aim of the study was to analyze the incidence of malignant neoplasms of the organs of the reproductive system of the population aged 15 to 39 years within the Russian Federation.Material and methods. The data of specialized forms of state reporting No. 7 “Information on diseases of malignant neoplasms” and data of the Federal State Statistics Service of the Russian Federation on the size and sex and age composition of the population for the period from 2011 to 2021 were used.Results. In the dynamics of changes in the incidence of malignant neoplasms of the reproductive organs of the young population of the regions of the Russian Federation for the period from 2011 to 2021, multidirectional trends are observed. The highest incidence rates are in the Siberian and Far Eastern Federal Districts, namely in the Trans-Baikal Territory and the Magadan Region, the smallest – in the regions of the North Caucasian Federal District.Conclusions. Regional differences in incidence rates in the constituent entities of the Russian Federation were established, changes in trends were found for the age group of people from 15 to 39 years old, which may be associated with lifestyle changes, environmental factors, as well as improved detection of cancer.
- Open Access
- 17 March 2022
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 21 (1) , 103-109
Interdisciplinary Approach to Improving the Reproductive Health of Adolescents and Adults
Междисциплинарный подход к улучшению репродуктивного здоровья подростков и взрослого населения
- 17 March 2022
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 21 (1) , 103-109
Open AccessInterdisciplinary Approach to Improving the Reproductive Health of Adolescents and Adults
Междисциплинарный подход к улучшению репродуктивного здоровья подростков и взрослого населения